Clincosm LogoSign in Get a demo

IATROPREV: Optimization of Drug Prescriptions in the Care Pathway for the Elderly, With the Final Objective of Reducing the Iatrogenic Risk

Sponsor
Centre Hospitalier Universitaire, Amiens (Other)
Overall Status
Recruiting
CT.gov ID
NCT05045235
Collaborator
(none)
1,500
Enrollment
1
Location
48
Anticipated Duration (Months)
31.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The IATROPREV project is an organizational innovation experimentation project, carried out in Hauts-de-France by the University hospitals of Amiens and Lille, the ARS and the URPS Doctors and Pharmacists of Hauts-de-France and following to the social security financing law of 2018, allowing experimentation with new organizations in the health sector, according to article 51. The objectives of this course are to improve the relevance of prescription in elderly people with multiple drugs as well as, the coordination of care between the city and the hospital through the sharing of information and the establishment of multi-professional consultations between the various care actors.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    1500 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Optimization of Drug Prescriptions in the Care Pathway for the Elderly, With the Final Objective of Reducing the Iatrogenic Risk.
    Actual Study Start Date :
    Sep 1, 2021
    Anticipated Primary Completion Date :
    Sep 1, 2025
    Anticipated Study Completion Date :
    Sep 1, 2025

    Outcome Measures

    Primary Outcome Measures

    1. Change of side effect number in ederly with polymedicated drugs [up to 4 years]

      Change of side effect number in ederly with polymedicated drugs

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • patient hospitalized in the geriatric medicine department

    • Potential involvement of a drug in hospitalization or potential or proven iatrogenic event during hospitalization;

    • Numerous therapeutic modifications (3 or more);

    • Drug interaction or introction of a new drug with one or more drug interactions;

    • Medicinal product with a narrow therapeutic marge drug requiring close monitoring.

    Exclusion Criteria:
    • patient non hospitalized in the geriatric medicine department

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Amiens University Hospital Amiens France 80054

    Sponsors and Collaborators

    • Centre Hospitalier Universitaire, Amiens

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Centre Hospitalier Universitaire, Amiens
    ClinicalTrials.gov Identifier:
    NCT05045235
    Other Study ID Numbers:
    • PI2021_843_0158
    First Posted:
    Sep 16, 2021
    Last Update Posted:
    Sep 21, 2021
    Last Verified:
    Sep 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Centre Hospitalier Universitaire, Amiens
    iatrogenic
    prescription
    follow-up
    consultation

    Study Results

    No Results Posted as of Sep 21, 2021